Related Experiment Videos
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR
J T Grayston1, L A Campbell, C C Kuo
1Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle 98195.
The Journal of Infectious Diseases
|April 1, 1990
Summary
Chlamydia pneumoniae strain TWAR causes pneumonia and respiratory infections, affecting nearly everyone globally. While often mild, severe cases and transmission necessitate prompt diagnosis and treatment.
Area of Science:
- Infectious Diseases
- Respiratory Medicine
- Microbiology
Background:
- Chlamydia pneumoniae strain TWAR is a newly identified species of Chlamydia.
- It is a significant cause of pneumonia and acute respiratory tract infections.
Purpose of the Study:
- To summarize the epidemiology, clinical presentation, and management of Chlamydia pneumoniae strain TWAR infections.
- To highlight its global prevalence and impact on respiratory health.
Main Methods:
- Review of existing literature and epidemiological data on TWAR infections.
- Analysis of population prevalence antibody studies.
Main Results:
- TWAR strain accounts for approximately 10% of pneumonia cases.
- Infections are widespread globally, with most individuals experiencing reinfection throughout their lifetime.
- Common in all age groups except children under 5 in temperate regions.
Conclusions:
- Chlamydia pneumoniae strain TWAR is a major global cause of respiratory illness.
- Effective treatment involves tetracycline or erythromycin.
- Further research into diagnosis and prevention is warranted.